| 000 | 01756 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514014621.0 | ||
| 264 | 0 | _c20020320 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0161-6412 | ||
| 024 | 7 |
_a10.1179/016164101101199117 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBednar, M M | |
| 245 | 0 | 0 |
_aThe effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis. _h[electronic resource] |
| 260 |
_bNeurological research _cOct 2001 |
||
| 300 |
_a745-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aAspirin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAtenolol _xpharmacology |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
| 650 | 0 | 4 |
_aDrug Interactions _xphysiology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
| 650 | 0 | 4 |
_aHydralazine _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aProstaglandins, Synthetic _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aThromboembolism _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xmethods |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aGross, C E | |
| 700 | 1 | _aHoward, D B | |
| 700 | 1 | _aRussell, S R | |
| 700 | 1 | _aEllenberger, C | |
| 773 | 0 |
_tNeurological research _gvol. 23 _gno. 7 _gp. 745-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1179/016164101101199117 _zAvailable from publisher's website |
| 999 |
_c11597486 _d11597486 |
||